Critic at Large

» disease/medicine and regulation

Most Recent

image: Three-Way Parenthood

Three-Way Parenthood

By , and | October 1, 2013

Avoiding the transmission of mitochondrial disease takes a trio, but raises a host of logistical issues.

2 Comments

image: Cancer Clinical Trials of Tomorrow

Cancer Clinical Trials of Tomorrow

By | April 1, 2013

Advances in genomics and cancer biology will alter the design of human cancer studies.

0 Comments

image: DIYbio: Low Risk, High Potential

DIYbio: Low Risk, High Potential

By | March 1, 2013

Citizen scientists can inspire innovation and advance science education—and they are proving adept at self-policing.

5 Comments

image: Regulating Amateurs

Regulating Amateurs

By | March 1, 2013

How should the government ensure the safety and responsibility of do-it-yourself biologists?

2 Comments

image: Genomics-Informed Pathology

Genomics-Informed Pathology

By | January 1, 2013

Twenty-first century lab reports will include test results read by a new breed of pathologist.

1 Comment

image: Medicines for the World

Medicines for the World

By | October 1, 2012

A global R&D treaty could boost innovation and improve the health of the world’s poor—and rich.

0 Comments

image: Polypharmacy

Polypharmacy

By | July 1, 2012

Dietary supplements can have serious side effects when mixed with prescription drugs, but not all herb-drug interactions are bad.

14 Comments

image: Regulations for Biosimilars

Regulations for Biosimilars

By | June 1, 2012

As biologic drug patents begin to expire, generic versions will hit the market—but how will they be regulated?

2 Comments

image: Antibiotics in the Animals We Eat

Antibiotics in the Animals We Eat

By | April 1, 2012

Low-dose antibiotics in animal feed fuel drug-resistance in human infectious diseases.

0 Comments

image: Toads

Toads

By | August 1, 2011

Ascribing benefits to the experience of devastating illness or trauma is fraught with hidden dangers.

33 Comments

Popular Now

  1. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Sequencing Reveals Genomic Diversity of the Human Brain
  4. What Sensory Receptors Do Outside of Sense Organs
RayBiotech